September 20, 2017 1:22 PM ET


Company Overview of Primus Therapeutics, Inc.

Key Executives for Primus Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Dennis M. O'Donnell R.Ph., MBA3 RelationshipsCo-Founder, Chief Executive Officer, President and Director61
Mark I. Massad CPANo RelationshipsChief Financial Officer and Principal Accounting Officer--

Primus Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Joseph A. Falsetti 10 RelationshipsPrimus Therapeutics, Inc.60
Dennis M. O'Donnell R.Ph., MBA 3 RelationshipsPrimus Therapeutics, Inc.61
Robert Joseph Hariri M.D., Ph.D. 117 RelationshipsMYOS RENS Technology Inc.58
Andrew M. Sadosky 3 RelationshipsPrimus Therapeutics, Inc.63
View All Board Members

Primus Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Andrew M. Sadosky3 Relationships2 Executives
Compensation Committee M.D., Ph.D.Robert Joseph Hariri117 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$215.0K
Total Value of Options
Compensation as of Fiscal Year
Primus Therapeutics, Inc. CEO Compensation
Industry Average


Huaren Pharmaceutical Announces Executive Changes; and Approves Cash Dividend of 2016
September 19, 2017 3:32 PM ET
FluGen Inc. Names Robert Belshe as Chairman of its Clinical Advisory Board
September 19, 2017 2:00 PM ET
Juniper Pharmaceuticals, Inc. Approves Reduction of Workforce by Approximately 8%; Announces Resignation of Bridget Martell, M.D. as Chief Medical Officer
September 19, 2017 12:34 PM ET
PLx Pharma Inc. Announces Executive Appointments
September 19, 2017 10:50 AM ET
Aerie Pharmaceuticals, Inc. Announces Executive Changes
September 19, 2017 10:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Primus Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at